cyc 202 has been researched along with Colorectal Cancer in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Joshi, KS; Manohar, SM | 1 |
| Abaza, MS; Al-Attiyah, RJ; Bahman, AM | 1 |
| Blake, D; Clarke, R; Cowan, A; Cummings, L; Fischer, PM; Lane, DP; MacKenzie, M; McClue, SJ; Melville, J; Stewart, K; Wang, S; Zhelev, N; Zheleva, D | 1 |
| Doyle, B; Geller, JI; Houghton, JA; Petak, I; Szekely-Szucs, K | 1 |
4 other study(ies) available for cyc 202 and Colorectal Cancer
| Article | Year |
|---|---|
Molecular pharmacology of multitarget cyclin-dependent kinase inhibitors in human colorectal carcinoma cells.
Topics: Cell Line, Tumor; Colorectal Neoplasms; Cyclin-Dependent Kinases; Humans; Protein Kinase Inhibitors; Roscovitine; Signal Transduction | 2023 |
Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Colorectal Neoplasms; DNA Fragmentation; Dose-Response Relationship, Drug; Doxorubicin; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Humans; Paclitaxel; Purines; Roscovitine; Time Factors; Vinblastine | 2008 |
In vitro and in vivo antitumor properties of the cyclin dependent kinase inhibitor CYC202 (R-roscovitine).
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Division; Colorectal Neoplasms; Cyclin E; Cyclin-Dependent Kinases; Enzyme Inhibitors; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Purines; Recombinant Proteins; Roscovitine; Transplantation, Heterologous; Tumor Cells, Cultured | 2002 |
P21Cip1 is a critical mediator of the cytotoxic action of thymidylate synthase inhibitors in colorectal carcinoma cells.
Topics: Apoptosis; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Drug Synergism; Enzyme Inhibitors; fas Receptor; G1 Phase; HCT116 Cells; HT29 Cells; Humans; Interferon-gamma; Purines; Quinazolines; Roscovitine; S Phase; Thymidylate Synthase | 2004 |